Senti Bio Announces Multiple Data Presentations at the
– Two poster presentations highlighting new preclinical data with BlueRock Therapeutics – – Two poster presentations showcasing Senti Bio’s proprietary...
Stay updated with breaking news from Timothy Lu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Two poster presentations highlighting new preclinical data with BlueRock Therapeutics – – Two poster presentations showcasing Senti Bio’s proprietary...
Researchers from MIT, Boston University, the University of Chicago, Analog Devices, and Brigham and Women’s Hospital have developed a tiny...
A new smart pill the size of a blueberry could be a game changer in the diagnosis and treatment of bowel diseases.
– Celadon Partners to acquire Senti’s manufacturing facility and CMC capabilities to establish GeneFab, an independent manufacturing business for cell and gene therapies – – Transaction... -Today at 08:36 am- MarketScreener
20.05.2023 - Five presentations showcase the modularity and applicability of Senti’s Gene Circuit technology in NK cells, T cells, AAVs, iPSCs, and macrophagesSOUTH SAN FRANCISCO, Calif., May 20, 2023 (GLOBE NEWSWIRE) - Senti Biosciences, Inc. (Nasdaq: SNTI) ... Seite 1